Net Sales
Breakdown
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Cardiovascular | $3.18B | $3.01B | $3.10B | $3.04B | $3.68B | $3.29B | $3.44B | $3.46B |
| Neuroscience | $2.41B | $2.32B | $2.45B | $2.46B | $2.52B | $2.42B | $2.56B | $2.56B |
| Medical Surgical | $1.98B | $2.00B | $2.13B | $2.07B | $2.18B | $2.08B | $2.17B | $2.17B |
| Diabetes Group | $693.00M | $647.00M | $686.00M | $694.00M | $784.00M | $721.00M | $757.00M | $796.00M |
| Other operating segment | — | — | — | $32.00M | $36.00M | $33.00M | $35.00M | $32.00M |
| Total | $8.23B | $7.92B | $8.40B | $8.29B | $9.25B | $8.58B | $8.96B | $9.02B |
Other Segment is derived from annual filings.
Segments
Other operating segmentView metric
NeuroscienceView metric
Medical SurgicalView metric
Reportable segment net salesView metric
Diabetes GroupView metric
CardiovascularView metric
Other SegmentView metric